NasdaqGM - Nasdaq Real Time Price USD
Actuate Therapeutics, Inc. Common stock (ACTU)
8.93
-0.07
(-0.78%)
As of 12:14:27 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Operating Cash Flow
-21,842.65
-21,842.65
-21,625.17
-17,794.09
Financing Cash Flow
27,525.61
27,525.61
4,134.52
19,255.57
End Cash Position
8,641.62
8,641.62
2,958.66
20,449.31
Income Tax Paid Supplemental Data
0.80
0.80
--
--
Interest Paid Supplemental Data
71.03
71.03
--
--
Issuance of Capital Stock
23,956.80
23,956.80
4,134.52
19,255.57
Issuance of Debt
5,700
5,700
--
--
Repayment of Debt
-200
-200
--
--
Free Cash Flow
-21,842.65
-21,842.65
-21,625.17
-17,794.09
12/31/2022 - 8/13/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RNTX Rein Therapeutics Inc.
1.7500
-3.85%
CUE Cue Biopharma, Inc.
0.8011
-4.21%
APTOF Aptose Biosciences Inc.
2.1800
-5.63%
COYA Coya Therapeutics, Inc.
6.49
-1.14%
RNXT RenovoRx, Inc.
0.9600
-2.04%
CGTX Cognition Therapeutics, Inc.
0.3952
+3.19%
TRML Tourmaline Bio, Inc.
17.47
-1.96%
INAB IN8bio, Inc.
0.1897
+3.97%
ABVX ABIVAX Société Anonyme
7.13
+5.40%
MLYS Mineralys Therapeutics, Inc.
13.80
+2.00%